
NYSE:SJM
This summary was created by AI, based on 4 opinions in the last 12 months.
J. M. Smuckers Co. (SJM) is facing significant headwinds, particularly after its acquisition of Hostess Brands, which coincides with the rise of GLP-1 weight-loss drugs. Analysts highlight a troubling outlook for the company, with expectations of a 9% decline in forward earnings growth for FY2026 and significant downward revisions to earnings estimates due to declining volumes and higher input costs. Although the stock has a cheap valuation at 10.3X forward earnings and a relatively attractive dividend yield of 4.6%, concerns loom over margin compression as consumers trade down. The packaged treat sector overall is struggling, pushed down by rising input costs and weak growth rates, leading some analysts to suggest caution before investing further in Smuckers. Observing key technical indicators, some investors are advised to wait for signs of recovery before making any decisions.
Incredibly well run. 40% of sales and 50% of profits is from coffee. Huge margins of 25% on coffee. Their jellies and jams, etc. continues to do well. They are very great act making small acquisitions in specialty things. Had some issues on the costs of inputs into their products, which has hurt margins a little. Thinks this will be stabilizing. They also increase dividends and buybacks shares. Trades at about 18X earnings with a 2.1% yield.
It is ripe for consolidation. It is always a bit of a richly valued company. Food and beverage is traditionally the safe place to be. They have done a good job with reinvestment opportunities. They have a long term record of growth and sustainable results.